Further evidence needed to change policy for the safe and effective radical cure of vivax malaria

Insights from the 2019 annual Apmen Vivax Working Group meeting

Bibliographic Data

ID13012305
AuthorsVarunika Ruwanpura (0000-0002-2003-5927, Charles Darwin University), Spike Nowak (Program for Appropriate Technology in Health), Emily Gerth‐Guyette (0000-0002-3719-3892, Program for Appropriate Technology in Health), Minerva Theodora (National Institute of Malaria Research), Dysoley Lek (Cambodia National Malaria Center), Mebratom Haile (Federal Ministry of Health), Koen Peeters Grietens (0000-0001-6570-9887, Nagasaki University), Richard N Price (0000-0003-2000-2874, Mahidol University), Caroline A Lynch (0000-0003-0072-0473, London School of Hygiene & Tropical Medicine), Kamala Thriemer (0000-0001-7536-7497, Charles Darwin University, corresponding author)
Year2021
Volume8
Issue2
Pages208-242
Publication date2021-01-12
Open AccessYes
TypeARTICLE
VenueAsia & the Pacific Policy Studies (JOURNAL)
Journal identifiersISSN: 2050-2680 • E-ISSN: 2050-2680
PublisherWiley (PUBLISHER • GB)
DOI10.1002/app5.314
PMID34820128
OpenAlexW3124211616
LanguageEN
Citations received3
References cited42

New diagnostics and treatment options for the radical cure of Plasmodium vivax malaria are now available. At the 2019 annual meeting of the Vivax Working Group of the Asia Pacific Malaria Elimination Network, participants took part in a roundtable discussion to identify further evidence required to introduce these new tools into policy and practice. Key gaps identified were accuracy and reliability of glucose-6-phosphate-dehydrogenase deficiency tests, health system capacity, and feasibility and cost effectiveness of novel treatment strategies in routine clinical practice. As expected, there were differences in the priorities between country partners and researcher partners. To achieve the 2030 target for the regional elimination of malaria, evidence to address these issues should be generated as a matter of priority. Review of global guidelines alongside locally generated data will help to ensure the timely revision and optimisation of national treatment guidelines that will be vital to meet regional elimination goals

Malaria · Plasmodium falciparum · Plasmodium vivax · Political science · Hemoglobinopathies and Related Disorders · Malaria Research and Control · Medicine · Mosquito-borne diseases and control · Immunology

Tools

Open DOIOpen Access